Eletriptan
RxNorm 231049
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 231049 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: eletriptan.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Eletriptan
(Atom ID: 1207054)
PTPrescribable
Designated preferred name (PT):
Eletriptan
(Atom ID: 1207058)
FNPrescribable
Full form of descriptor (FN):
Eletriptan (substance)
(Atom ID: 1207063)
PTPrescribable
Designated preferred name (PT):
Eletriptan-containing product
(Atom ID: 10802027)
FNPrescribable
Full form of descriptor (FN):
Product containing eletriptan (medicinal product)
(Atom ID: 9256591)
Patient Education
Eletriptan
Eletriptan is used to treat the symptoms of migraine headaches (severe throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound and light). Eletriptan is in a class of medications called selective serotonin receptor agonists. It works by narrowing blood vessels in the brain, stopping pain signals from being sent to the brain, and blocking the release of certain natural substances that cause pain, nausea, and other symptoms of migraine. Eletriptan does not prevent migraine attacks or reduce the number of headaches you have.
[Learn More]
* Please review the disclaimer below.